Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$526K Buy
973
+214
+28% +$110K ﹤0.01% 3648
2026
Q1
$330K Buy
759
+59
+8% +$26K ﹤0.01% 3732
2025
Q4
$230K Buy
+700
New +$225K ﹤0.01% 3887
2025
Q3
Sell
-2,070
Closed -$570K 4144
2025
Q2
$570K Buy
2,070
+161
+8% +$32.8K ﹤0.01% 3487
2025
Q1
$352K Sell
1,909
-17
-0.9% -$3.93K ﹤0.01% 3629
2024
Q4
$379K Buy
1,926
+68
+4% +$13.1K ﹤0.01% 3627
2024
Q3
$387K Sell
1,858
-10
-0.5% -$2.13K ﹤0.01% 3569
2024
Q2
$438K Buy
1,868
+60
+3% +$11.9K ﹤0.01% 3460
2024
Q1
$321K Sell
1,808
-657
-27% -$104K ﹤0.01% 3565
2023
Q4
$339K Buy
2,465
+385
+19% +$44.5K ﹤0.01% 3576
2023
Q3
$234K Sell
2,080
-5
-0.2% -$588 ﹤0.01% 3653
2023
Q2
$245K Buy
+2,085
New +$213K ﹤0.01% 3669

Other funds holding NVMI

Ameriprise's NVMI Position: Q2 2026 in Review

Ameriprise increased its Nova (NVMI) stake by 28% in Q2 2026, buying an estimated $110K and bringing the position to 973 shares worth $526K. The position accounts for ﹤0.01% of the portfolio, ranked #3648.

Ameriprise first reported a position in NVMI in Q2 2023 and has held it in 12 quarters since. The position peaked at $570K in Q2 2025. 345 funds tracked by Wall St. Rank hold NVMI as of Q2 2026.

  • Ameriprise held 973 shares of Nova worth $526K as of Q2 2026.
  • Ameriprise bought 214 Nova shares in Q2 2026, an estimated $110K.
  • Nova made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #3648 holding.
  • Ameriprise first reported a position in Nova in Q2 2023 and has held it in 12 quarters since.
  • Ameriprise's Nova position peaked at $570K in Q2 2025.
  • 345 funds tracked by Wall St. Rank held Nova as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.